Steroidogenesis in rat brain induced by short- and long-term administration of carbamazepine

Neuropharmacology

Volumn 39, Issue 12, 2000, Pages 2448-2456

  Serra, Mariangela ^a,b   Littera, Martino ^a   Pisu, M Giuseppina ^a   Muggironi, Michela ^a   Purdy, Robert H ^c   Biggio, Giovanni ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbamazepine; Convulsions; Neurosteroids; Rat brain

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; NEUROSTEROID; PREGNENOLONE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; STEROIDOGENESIS;

ANIMALS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BRAIN CHEMISTRY; CARBAMAZEPINE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; ISOQUINOLINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; STEROIDS;

EID: 0033884102     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00086-1     Document Type: Article

References (42)

1. Ashton H. The treatment of benzodiazepine dependence. Addiction. 89:1994;1535-1537.
2. Ballenger J.C. The clinical use of carbamazepine in affective disorders. Journal of Clinical Psychiatry. 49:1988;13-21.
3. Bancroft J., Cook A., Davidson D., Bennie J., Goodwin G. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychological Medicine. 21:1991;305-312.
4. Belelli D., Bolger M.B., Gee K.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. European Journal of Pharmacology. 166:1989;325-329.
5. A receptor. Brain Research. 561:1991;157-161.
6. Björkqvist S.E., Isohanni M., Mäkelä R. Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubleblind comparison with placebo. Acta Psychiatrica Scandinavica. 53:1976;333-342.
7. Bonduelle M. Current approaches to the treatment of trigeminal neuralgia. Birkmayer W. Epileptic Seizures - Behavior - Pain. 1976;321-326 Hans Huber, Bern.
8. 1 binding sites. European Journal of Pharmacology. 164:1989;399-401.
9. 35S]TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. British Journal of Pharmacology. 118:1996;839-846.
10. Elphick M., Anderson S.M.P., Hallis K.F., Grahame Smith D.G. Effects of carbamazepine on 5-hydroxytryptamine function in rodents. Psychopharmacology. 100:1990;49-53.
11. A receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroids and benzodiazepine recognition sites. Molecular Pharmacology. 44:1993;191-197.
12. Granger P., Biton B., Faure C., Vige X., Depoortere H., Graham D.et al. Modulation of the γ-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Molecular Pharmacology. 47:1995;1189-1196.
13. Guarneri P., Papadopoulos V., Pan B., Costa E. Regulation of pregnenolone synthesis in C6-2B glioma cells by 4′-chlorodiazepam. Proceedings of the National Academy of Sciences of the United States of America. 89:1992;5118-5122.
14. Horton W.R., Chapman G., Meldrum B.S. Isoniazid as a glutamic acid decarboxylase inhibitor. Journal of Neurochemistry. 33:1979;745-749.
15. Jorgensen H., knigge U., Kjaer A., Warberg J. Adrenocorticotropic hormone secretion in rats induced by stimulation with serotoninergic compounds. Journal of Neuroendocrinology. 11:1999;283-290.
16. Kokate T.G., Svensson B.E., Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. Journal of Pharmacology and Experimental Therapeutics. 270:1994;1223-1229.
17. Kokate T.G., Yamaguchi S., Pannel I.K., Ramajamani U., Carrol D.M., Grossman A.B.et al. Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. Journal of Pharmacology and Experimental Therapeutics. 287:1998;553-558.
18. A receptor function. Trends in Pharmacological Science. 16:1995;295-303.
19. Lancaster J.M., Davies J.A. Carbamazepine inhibits NMDA-induced depolarization in cortical wedges prepared from DBA/2 mice. Experientia. 48:1992;751-753.
20. Le Fur G., Perrier M.L., Vaucher N., Imbant F., Flamier A., Uzan A.et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinoline-carboxamide I. In vitro studies. Life Science. 32:1983;1839-1847.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-276.
22. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
23. Marangos P.J., Post R.M., Patel J., Zander K., Parma A., Weiss S. Specific and potent interactions of carbamazepine with brain adenosine receptors. European Journal of Pharmacology. 93:1983;175-182.
24. Mattson R.H., Cramer J.A., Collins J.F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veteran Affairs Epilepsy Cooperative Study No. 264 Group. New England Journal of Medicine. 327:1992;765-771.
25. Mendelson W.B., Martin J.V., Perlis M., Wagner R., Majewska M.D., Paul S.M. Sleep induction by adrenal steroid in the rat. Psychopharmacology. 93:1987;226-229.
26. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocrine Reviews. 14:1993;222-240.
27. Post R.M., Altschuler L.L., Ketter T., Denicoff K., Weiss S.R.B. Antiepileptic drugs in affective illness: clinical and theoretical implications. Smith D.B., Treiman D.M., Trimble M.R. Advances in Neurobiology - Neurobehavioral Problems in Epilepsy. 1991;239-277 Raven, New York.
28. Post R.M., Denicoff K.D., Frye M.A., Dunn R.T., Leverich G.S., Osuch E.et al. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology. 38:1998;152-166.
29. Potts G.O., Creange J.E., Harding H.R., Schane H.P. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids. 32:1978;257-267.
30. Purdy R.E., Julien R.M., Fairhurst A.S., Terry M.D. Effect of carbamazepine on the in vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptoneurosomes. Epilepsia. 18:1977;251-257.
31. Romeo E., Auta J., Kozikowski A.P., Papadopoulos V., Puia G., Costa E.et al. 2-Aryl-3-indoacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). Journal of Pharmacology and Experimental Therapeutics. 262:1992;971-978.
32. Romeo E., Ströhle A., Spalletta G., Di Michele F., Hermann B., Holsboer F.et al. Effects of antidepressant treatment on neuroactive steroids in major depression. American Journal of Psychiatry. 155:1998;910-913.
33. Rupprecht R. The neuropharmacological potential of neuroactive steroids. Journal of Psychiatric Research. 3:1997;297-314.
34. Serra M., Madau P., Chessa M.F., Caddeo M., Sanna E., Trapani G.et al. 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action. British Journal of Pharmacology. 127:1999;177-187.
35. Ströhle A., Romeo E., Hermann B., Pasini A., Spalletta G., Di Michele F.et al. Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biological Psychiatry. 45:1999;274-277.
36. Tateishi T., Masako M., Nakura H., Watanabe M., Tanaka M., Kumai T.et al. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chemico-Biological Interactions. 117:1999;257-268.
37. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E.et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;3239-3244.
38. Weiss S.R.B., Post R.M. Contingent tolerance to carbamazepine: a peripheral-type benzodiazepine mechanism. European Journal of Pharmacology. 193:1991;159-163.
39. Weiss S.R.B., Post R.M., Patel J., Marangos P.J. Differential mediation of the anticonvulsant effects of carbamazepine and diazepam. Life Science. 36:1985;2413-2419.
40. A receptor subunit mRNA during chronic treatment of rats with diazepam. Journal of Molecular Neuroscience. 5:1994;105-120.
41. A receptor complex in mammalian cortical neurons. Journal of Pharmacology and Experimental Therapeutics. 275:1995;784-789.
42. A receptor subunit mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment. Molecular Brain Research. 41:1996;163-168.